122 related articles for article (PubMed ID: 6835989)
1. Influence of Z-Prolyl-D-Leucine on alpha-MPT-induced catecholamine utilization in specific mouse brain nuclei.
Kovács GL; Acsai L; Tihanyi A; Faludi M; Telegdy G
Pharmacol Biochem Behav; 1983 Mar; 18(3):345-9. PubMed ID: 6835989
[TBL] [Abstract][Full Text] [Related]
2. Catecholamine utilization in distinct mouse brain nuclei during acute morphine treatment, morphine tolerance and withdrawal syndrome.
Kovács GL; Acsai L; Tihanyi A; Telegdy G
Eur J Pharmacol; 1983 Sep; 93(3-4):149-58. PubMed ID: 6685650
[TBL] [Abstract][Full Text] [Related]
3. Drugs affecting brain dopamine interfere with the effect of Z-prolyl-D-leucine on morphine withdrawal.
Kovács GL; Telegdy G; Hódi K
Pharmacol Biochem Behav; 1984 Sep; 21(3):345-8. PubMed ID: 6541792
[TBL] [Abstract][Full Text] [Related]
4. Catecholamine utilization in specific rat brain nuclei after short-term hyperprolactinaemia.
Kovács GL; Drago F; Acsai L; Tihanyi A; Scapagnini U; Telegdy G
Brain Res; 1984 Dec; 324(1):29-34. PubMed ID: 6518390
[TBL] [Abstract][Full Text] [Related]
5. Interaction of vasopressin with the nigro-striatal dopamine system: site and mechanism of action.
van Heuven-Nolsen D; Versteeg DH
Brain Res; 1985 Jul; 337(2):269-76. PubMed ID: 4027572
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
Hallman H; Jonsson G
Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900
[TBL] [Abstract][Full Text] [Related]
7. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
Nissbrandt H; Engberg G; Pileblad E
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
[TBL] [Abstract][Full Text] [Related]
8. Pro-Leu-GlyNH2 affects dopamine and noradrenaline utilization in rat limbic-forebrain nuclei.
van Heuven-Nolsen D; de Kloet ER; Versteeg DH
Brain Res; 1984 Nov; 322(2):213-8. PubMed ID: 6150749
[TBL] [Abstract][Full Text] [Related]
9. Transmitter release from transplants of fetal ventral mesencephalon or locus coeruleus in the rat frontal cortex and nucleus accumbens: effects of pharmacological and behaviorally activating stimuli.
Cenci MA; Kalén P; Duan WM; Björklund A
Brain Res; 1994 Apr; 641(2):225-48. PubMed ID: 8012825
[TBL] [Abstract][Full Text] [Related]
10. Effect of des-Tyr1-gamma-endorphin and des-Tyr1-alpha-endorphin on alpha-MPT-induced catecholamine disappearance in rat brain nuclei: a dose--response study.
Versteeg DH; Kovács GL; Bohus B; de Kloet ER; de Wied D
Brain Res; 1982 Jan; 231(2):343-51. PubMed ID: 6120024
[TBL] [Abstract][Full Text] [Related]
11. Effects of oxytocin, des-glycinamide-oxytocin and anti-oxytocin serum on the alpha-MPT-induced disappearance of catecholamines in the rat brain.
Kovács G; Telegdy G
Brain Res; 1983 Jun; 268(2):307-14. PubMed ID: 6135495
[TBL] [Abstract][Full Text] [Related]
12. Biochemical mapping of the noradrenergic ventral bundle projection sites: evidence for a noradrenergic--dopaminergic interaction.
O'Donohue TL; Crowley WR; Jacobowitz DM
Brain Res; 1979 Aug; 172(1):87-100. PubMed ID: 466469
[TBL] [Abstract][Full Text] [Related]
13. Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex.
Fallon JH; Koziell DA; Moore RY
J Comp Neurol; 1978 Aug; 180(3):509-32. PubMed ID: 659673
[TBL] [Abstract][Full Text] [Related]
14. Brain catecholamines in spontaneously hypertensive and DOCA-salt hypertensive rats.
Fujino K
Acta Med Okayama; 1984 Aug; 38(4):325-40. PubMed ID: 6149670
[TBL] [Abstract][Full Text] [Related]
15. Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography.
Donnan GA; Kaczmarczyk SJ; Paxinos G; Chilco PJ; Kalnins RM; Woodhouse DG; Mendelsohn FA
J Comp Neurol; 1991 Feb; 304(3):419-34. PubMed ID: 2022757
[TBL] [Abstract][Full Text] [Related]
16. Oxytocin and a C-terminal derivative (Z-prolyl-D-leucine) attenuate tolerance to and dependence on morphine and interact with dopaminergic neurotransmission in the mouse brain.
Kovács GL; Horváth Z; Sarnyai Z; Faludi M; Telegdy G
Neuropharmacology; 1985 May; 24(5):413-9. PubMed ID: 2991800
[TBL] [Abstract][Full Text] [Related]
17. Behavioural and electrocortical changes induced by paraquat after injection in specific areas of the brain of the rat.
De Gori N; Froio F; Strongoli MC; De Francesco A; Calò M; Nisticò G
Neuropharmacology; 1988 Feb; 27(2):201-7. PubMed ID: 3352874
[TBL] [Abstract][Full Text] [Related]
18. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures.
Kovács GL; Bohus B; Versteeg DH; de Kloet ER; de Wied D
Brain Res; 1979 Oct; 175(2):303-14. PubMed ID: 487159
[TBL] [Abstract][Full Text] [Related]
19. Effect of 6-hydroxydopamine-induced lesions to ascending and descending noradrenergic pathways on morphine analgesia.
Sawynok J; Reid A
Brain Res; 1987 Sep; 419(1-2):156-65. PubMed ID: 3119144
[TBL] [Abstract][Full Text] [Related]
20. Differences in the effects of morphine on the alpha-methyl-p-tyrosine-induced depletion of dopamine and noradrenaline in various areas of the mouse brain.
Martti L; Attila J; Etemadzadeh E; Ahtee L
Pharmacol Toxicol; 1987 Jul; 61(1):26-32. PubMed ID: 3628178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
